The International Business Times covers a new study showing “trials for new antidepressant medications may not be applicable to the population at large.” “The finding, published in the Mayo Clinic Proceedings, shows recent trials are less generalizable than the prior studies, as researchers excluded most depressed patients from drug company-sponsored treatment studies.”
-
“Patients with co-morbid psychiatric disorders have become frequently excluded together with patients with any co-morbid Axis I disorder, which were twice as likely to be excluded in recent studies.”
Like “co-morbid” means anything in psychiatry. But the fact that they cherry-pick people to increase their chances of getting a positive result is not surprising. -
No study of major depression is generalizable… major depression is not a valid, reliable, nor demarcable illness.
